Skip to main content
MKP Mobility Limited logo

MKP Mobility Limited — Investor Relations & Filings

Ticker · 521244 ISIN · INE676G01024 BSE.NS Transportation and storage
Filings indexed 306 across all filing types
Latest filing 2022-11-11 Regulatory Filings
Country IN India
Listing BSE.NS 521244

About MKP Mobility Limited

https://mkpmobility.com

MKP Mobility Limited, formerly known as MK Proteins Limited, is an enterprise transitioning from edible oil production to the mobility sector. Historically, the company specialized in the manufacturing and refining of vegetable oils, including rice bran, sunflower, and cottonseed oils. Following its rebranding, the company has expanded its strategic focus to include the mobility industry, specifically targeting the electric vehicle (EV) ecosystem. Its operations encompass the development of EV charging infrastructure, the distribution of automotive components, and the exploration of sustainable transport solutions. By leveraging its industrial expertise, MKP Mobility aims to integrate traditional manufacturing strengths with emerging technologies in the clean energy and transportation segments.

Recent filings

Filing Released Lang Actions
Intimation of adoption of altered Memorandum of Association and Article of Association.
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to the Bombay Stock Exchange regarding the adoption of altered Memorandum of Association and Articles of Association following a postal ballot result. It mentions changes such as alteration of the Memorandum and Articles of Association, increase in authorized share capital, change of registered office, and company name change. The document is an intimation or announcement of these corporate changes, not the detailed report or the actual altered documents themselves. It is a regulatory announcement under SEBI Listing Obligations and Disclosure Requirements, indicating a corporate governance update. The document length is short (2046 characters), and it serves as a notification rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories like MANG (which is for board/management changes) or SHA (which is for share issues). This is not a management change announcement, nor a capital raising update, but a regulatory filing about corporate document amendments.
2022-11-11 English
Newspaper Advertisement regarding Postal Ballot Results.
Regulatory Filings
2022-11-11 English
As per the SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, issued by the SEBI titled "Format on Statement of Deviation or Variation for proceeds of Preferential Issue and ....
Regulatory Filings Classification · 95% confidence The document is a submission to the stock exchange (BSE Ltd.) regarding the Statement of Deviation/Variation in utilization of funds raised under SEBI regulations for the quarter ended September 30, 2022. It references SEBI Listing Obligations and Disclosure Requirements Regulation, 2015, and SEBI Circular No. CIR/CFD/CMD1/162/2019. The content is a compliance disclosure about the use of proceeds from a preferential issue of shares, confirming no deviation in fund utilization. The document is short (3489 characters) and serves as a regulatory compliance filing rather than a full financial report or detailed analysis. It is not an annual or interim report, earnings release, or capital update but a regulatory disclosure about fund utilization. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2022-11-10 English
With reference to the captioned subject, we enclose herewith Announcement of the Results of the Postal Ballot including e-voting as prescribed under Section 110 of the Companies Act, 2013 ....
Regulatory Filings
2022-11-10 English
CHITRADURGA SPINTEX LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve To consider and approve ....
Regulatory Filings Classification · 95% confidence The document is a notice of an upcoming Board Meeting scheduled to consider and approve unaudited financial results for the quarter and half year ended 30th September 2022. It is an announcement of the meeting date and agenda, not the financial results report itself. The document is short (1426 characters) and serves as an intimation to the stock exchange and public about the meeting and the expected financial results release. Therefore, it is not an Interim/Quarterly Report (IR) but rather a Regulatory Filing (RNS) as a general regulatory announcement about the Board Meeting and financial results release schedule.
2022-11-04 English
Please find enclosed herewith the Confirmation certificate received from M/s. Canbank Computer Services Limited, Registrar and Share Transfer Agent (RTA) in compliance with the Regulation ....
Regulatory Filings
2022-10-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.